Singleton et al(28) demonstrated that oral glutamine reduced the secretion of inflammatory cytokines, such as TNF-α, IL-6 and IL-18, in the lung tissues of rats with acute respiratory distress syndrome (ARDS), and protected lung tissue by the reducing the activation of NF-κB. Here, NFKB1 is linked to acute respiratory distress syndrome.